Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Richins Insider Profile
4 Followers
Paul Richins, Director at Utah Medical Products, holds 23.37K shares in Utah Medical Products (Ticker: UTMD). Most recently, Paul Richins Sold $650 shares of Utah Medical Products on May 28, 2020 for an estimated value of 62.21K.
Profitable Transactions
6 out of 9 Profitable Transactions
Average Return
+18.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Paul Richins holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 08, 2012 - Nov 08, 2013
Return:+65.50%
The most profitable trade made by Paul Richins
Paul Richins's Trading History
List of latest transactions for each holding click on a transaction to see Paul Richins's performance on stock
You May Also Like
Paul Richins insider profile FAQ
What is the percentage of profitable transactions made by Paul Richins?
The percentage of profitable transactions made by Paul Richins is 67%.
What is the average return per transaction made by Paul Richins?
The average return per transaction made by Paul Richins is 18.00%.
What stocks does Paul Richins hold?
Paul Richins holds: UTMD stocks.
What was Paul Richins’s latest transaction?
Paul Richins latest transaction was an Informative Sell of $62.21K.
What was Paul Richins's most profitable transaction?
Paul Richins’s most profitable transaction was an Informative Buy of UTMD stock on November 8, 2012. The return on the trade was 65.50%.
What is Paul Richins's role in Utah Medical Products?
Paul Richins's role in Utah Medical Products is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.